DEPUY LPS DIAPHYSEAL AND METAPHYSEAL SLEEVES— 510(k) K071417
Substantially EquivalentDePuy Orthopaedics, Inc.
FDA 510(k) clearance K071417 for DEPUY LPS DIAPHYSEAL AND METAPHYSEAL SLEEVES, Substantially Equivalent on 2007-08-02. Applicant: DePuy Orthopaedics, Inc.. Device class: 2.
Clearance details
- Applicant
- DePuy Orthopaedics, Inc.
- Product code
- Code MBH
- Device class
- Class 2
- Regulation
- 21 CFR 888.3565
- Advisory panel
- Orthopedic
- Date received
- Decision date
- Decision
- Substantially Equivalent
- Clearance type
- Traditional
- Location
- Warsaw, IN, US
Recent devices under product code MBH
view allMore clearances from DePuy Orthopaedics, Inc.
view allAdverse events under product code MBH
product code MBH- Injury
- 6,545
- Malfunction
- 2,023
- Total
- 8,568
Source: openFDA MAUDE database, through . Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →
Recalls naming K071417
K-number listed on FDA's recall record- Z-0828-2013 — LPS Diaphyseal Sleeves Product Usage: The LPS Diaphyseal Sleeves are used with the LPS System which is an end-stage revision knee product that allows surgeons to reconstruct severe soft tissue and bony defects.
- Z-0829-2013 — LPS Diaphyseal Sleeves Product Usage: The LPS Diaphyseal Sleeves are used with the LPS System which is an end-stage revision knee product that allows surgeons to reconstruct severe soft tissue and bony defects.
- Z-0830-2013 — LPS Diaphyseal Sleeves Product Usage: The LPS Diaphyseal Sleeves are used with the LPS System which is an end-stage revision knee product that allows surgeons to reconstruct severe soft tissue and bony defects.
- Z-0831-2013 — LPS Diaphyseal Sleeves Product Usage: The LPS Diaphyseal Sleeves are used with the LPS System which is an end-stage revision knee product that allows surgeons to reconstruct severe soft tissue and bony defects.
Matched by K-number from FDA's Recall Enterprise System record (openFDA device/recallk_numbers) — these recalls explicitly list K071417.
Data sourced from openFDA. This site is unofficial and independent of the FDA.